We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POSH
1701
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$454K ﹤0.01%
25,387
JELD icon
1702
JELD-WEN Holding
JELD
$164M
$453K ﹤0.01%
46,909
-2,176
-4% -$21.1K
MTUS icon
1703
Metallus
MTUS
$900M
$451K ﹤0.01%
24,844
RPT
1704
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$450K ﹤0.01%
44,784
JOBY icon
1705
Joby Aviation
JOBY
$8.17B
$448K ﹤0.01%
133,776
STKL
1706
DELISTED
SunOpta
STKL
$448K ﹤0.01%
53,076
SRCE icon
1707
1st Source
SRCE
$2.13B
$446K ﹤0.01%
8,408
-730
-8% -$39.8K
CLNE icon
1708
Clean Energy Fuels
CLNE
$384M
$446K ﹤0.01%
85,798
+1,919
+2% +$11.8K
KURA icon
1709
Kura Oncology
KURA
$882M
$445K ﹤0.01%
35,896
+946
+3% +$13.8K
BBIO icon
1710
BridgeBio Pharma
BBIO
$15.9B
$445K ﹤0.01%
58,444
ADPT icon
1711
Adaptive Biotechnologies
ADPT
$3.89B
$445K ﹤0.01%
58,266
PTRA
1712
DELISTED
Proterra Inc. Common Stock
PTRA
$445K ﹤0.01%
117,961
FATE icon
1713
Fate Therapeutics
FATE
$294M
$444K ﹤0.01%
44,004
MLAB icon
1714
Mesa Laboratories
MLAB
$631M
$443K ﹤0.01%
2,668
HIBB
1715
DELISTED
Hibbett, Inc. Common Stock
HIBB
$443K ﹤0.01%
6,500
CDMO
1716
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$443K ﹤0.01%
32,173
CHCT
1717
Community Healthcare Trust
CHCT
$430M
$442K ﹤0.01%
12,350
SPCE icon
1718
Virgin Galactic
SPCE
$475M
$442K ﹤0.01%
6,352
+411
+7% +$38.3K
TTEC icon
1719
TTEC Holdings
TTEC
$77.4M
$442K ﹤0.01%
10,010
CRAI icon
1720
CRA International
CRAI
$1.07B
$440K ﹤0.01%
3,595
-17
-0.5% -$1.87K
ARGO
1721
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$438K ﹤0.01%
16,963
PLOW icon
1722
Douglas Dynamics
PLOW
$981M
$438K ﹤0.01%
12,125
RC
1723
Ready Capital
RC
$289M
$438K ﹤0.01%
39,346
WWW icon
1724
Wolverine World Wide
WWW
$1.63B
$438K ﹤0.01%
40,100
-3,614
-8% -$48K
INVA icon
1725
Innoviva
INVA
$1.5B
$438K ﹤0.01%
33,073

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.